Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Pacault

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Antitumoral effect of celecoxib in hepatocellular carcinomaDavid Malka, Vincent Pacault, Thierry De Baere, et al.
Annales De Pathologie|December 17, 2008
[A case of giant cell microscopic colitis?]Juliette Duclos, Haitham Kussaibi, Vincent Pacault, et al.
BMC Cancer|March 28, 2012
Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapyPierre Blanchard, Laurent Quero, Vincent Pacault, et al.
Gastroenterology|June 16, 2007
CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactionsMatthieu Allez, Vannary Tieng, Atsushi Nakazawa, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Antitumoral effect of celecoxib in hepatocellular carcinomaDavid Malka, Vincent Pacault, Thierry De Baere, et al.
Annales De Pathologie|December 17, 2008
[A case of giant cell microscopic colitis?]Juliette Duclos, Haitham Kussaibi, Vincent Pacault, et al.
BMC Cancer|March 28, 2012
Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapyPierre Blanchard, Laurent Quero, Vincent Pacault, et al.
Gastroenterology|June 16, 2007
CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactionsMatthieu Allez, Vannary Tieng, Atsushi Nakazawa, et al.
Pageof 1